Lunan Pharma Valacyclovir Hydrochloride Tablets Passed the Consistency Evaluation
New Media Department Yu Jie, Duan Yuqing May 29, 2023
Recently, Valacyclovir Hydrochloride Tablets of Shandong New Time Pharmaceutical Co., Ltd. has been approved by the National Medical Products Administration to increase the specification of this product to 0.5g. At the same time, this specification has passed the consistency evaluation of generic drug quality and efficacy, the approval number is: Guoyao Zhunzi H20237057.
This product is suitable for treating herpes zoster, herpes simplex virus infection, and preventing (inhibiting) the recurrence of herpes simplex virus infection. Valacyclovir is an antiviral agent and is the L-valine ester of acyclovir. Acyclovir is a purine (guanine) nucleoside analogue. Valacyclovir is almost completely rapidly converted into acyclovir and valine by the action of valacyclovir hydrolase in the human body. Acyclovir is a specific inhibitor of herpes virus, and has the ability to inhibit herpes simplex virus (HSV) types 1 and 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and the role of human herpesvirus 6 (HHV-6). After being phosphorylated into an active triphosphate form, acyclovir can inhibit the synthesis of viral DNA.